Product Launch Recent ExoELISA-Step kit and Human Capture Beads launches indicate a rapidly expanding product portfolio in exosome research and isolation, presenting cross-sell and upsell opportunities to existing customers and channels involved in exosome analysis and diagnostic development.

IVD Expansion StarBright fluorescent dyes added to the IVD reagents for flow cytometry suggest a push into in vitro diagnostic workflows; target hospitals, CROs, and diagnostic labs using flow cytometry as potential customers for new dyes and compatible reagent kits.

SMB Focus With a sub-$1M revenue base and a small-to-mid-sized team (11–50 employees), there is room for focused account-based selling to academic labs, biotech startups, and contract research organizations seeking specialized ELISA, exosome, and flow cytometry reagents.

Tech Stack Advantage Utilize the company’s digital footprint and tools (WordPress, Shopify/WooCommerce, ActiveCampaign, Hotjar/Clarity) to craft targeted content, nurture campaigns, and optimize e-commerce and lead capture for new product lines and global distribution partners.

Global Collaboration Strategic partnerships and collaborations in clinical research and diagnostics could accelerate adoption; pursue collaborations with labs and research networks that require exosome detection, isolation, and advanced dye reagents, expanding reach beyond current channels.